Procedure Volume Patient Data Patient Conditions Reviews General Payments Back to Top

Home > CA Providers

Dr. Richard Samuel Finn, MD

(No ratings)

Specializes in: Medical Oncology, Adult Oncology and Adult Hematology

University of California, Los Angeles (UCLA), David Geffen School of Medicine (1997)

2020 Santa Monica Boulevard Suite 580
Santa Monica, CA 90404

(310) 829-5471

Dr. Richard Samuel Finn, MD is a medical oncologist in Los Angeles, CA specializing in medical oncology, adult oncology and adult hematology. He graduated from University of California, Los Angeles (UCLA), David Geffen School of Medicine in 1997 and has 27 years of experience. Dr. Richard Samuel Finn, MD is affiliated with UCLA Health, Ronald Reagan UCLA Medical Center, Huntington Health, Huntington Hospital, UCLA Santa Monica Medical Center and THE REGENTS OF THE UNIVERSITY OF CALIFORNIA.

Office Locations

Address:

100 Medical Plaza Suite 700
Los Angeles, CA 90095

Address:

15503 Ventura Boulevard Suite 150
Encino, CA 91436

Address:

2020 Santa Monica Boulevard Suite 580
Santa Monica, CA 90404

Address:

625 S Fair Oaks Avenue Suite 320
Pasadena, CA 91105

In The News (see more mentions in the news)

“Fostrox, with its unique, liver-targeted mechanism has the potential to minimize the tumor burden locally in the liver and provide synergistic activity with existing medical treatments and improve...”—"Cision PR Newswire", KRON4, August 2023

“At UCLA, Dr. Richard Finn, a clinical professor of hematology and oncology, reported outside income of exactly $40,000 during the 2016-17 academic year.”—"UC professors fail to report outside income, shortchanging the university system", Los Angeles Times, December 2019

“"We found that the degree of clinical benefit was, again, remarkable," said lead researcher Dr. Richard Finn, an assistant professor of medicine at the University of California, Los Angeles.”—"Drug can help slow advanced breast cancer", CBS Philly, November 2016

blood draw	58
doctor visit	501
hospital care	276
inpatient care	276
lab tests	130

**Gender**
Male	154
Female	100

**Ethnicity**
Non-Hispanic White	131
Black	0
Hispanic	57
Asian	49
Other	0
Native American	0

**Age**
From 65 to 74	113
From 75 to 84	66
85 and over	22
Less than 65	53

Hypertension	71
High Cholesterol	39
Stroke	0
Ischemic Heart Disease	50
Depression	20
Chronic Kidney Disease	47
Asthma	11
Osteoperosis	9
Atrial Fibrilation	12
Heart Failure	30
Chronic Obstructive Pulmonary Disease	17
Diabetes	45
Dementia	9
Cancer	21

blood draw	65
doctor visit	423
hospital care	250
inpatient care	250
lab tests	109

**Gender**
Male	151
Female	107

**Ethnicity**
Non-Hispanic White	126
Black	0
Hispanic	56
Asian	55
Other	0
Native American	0

**Age**
From 65 to 74	118
From 75 to 84	57
85 and over	18
Less than 65	65

Hypertension	68
High Cholesterol	37
Stroke	7
Ischemic Heart Disease	43
Depression	23
Chronic Kidney Disease	45
Asthma	10
Osteoperosis	10
Atrial Fibrilation	10
Heart Failure	25
Chronic Obstructive Pulmonary Disease	16
Diabetes	44
Dementia	8
Cancer	24

blood draw	82
doctor visit	508
hospital care	362
inpatient care	362
lab tests	230

**Gender**
Male	334
Female	228

**Ethnicity**
Non-Hispanic White	302
Black	0
Hispanic	116
Asian	100
Other	0
Native American	0

**Age**
From 65 to 74	306
From 75 to 84	120
85 and over	30
Less than 65	106

Hypertension	72
High Cholesterol	38
Stroke	7
Ischemic Heart Disease	46
Depression	25
Chronic Kidney Disease	52
Asthma	14
Osteoperosis	10
Atrial Fibrilation	12
Heart Failure	22
Chronic Obstructive Pulmonary Disease	15
Diabetes	41
Dementia	9
Cancer	21

blood draw	70
doctor visit	632
hospital care	305
inpatient care	305
lab tests	276

**Gender**
Male	196
Female	132

**Ethnicity**
Non-Hispanic White	166
Black	26
Hispanic	74
Asian	50
Other	0
Native American	0

**Age**
From 65 to 74	171
From 75 to 84	78
85 and over	20
Less than 65	59

Hypertension	72
High Cholesterol	45
Stroke	8
Ischemic Heart Disease	48
Depression	27
Chronic Kidney Disease	55
Asthma	17
Osteoperosis	9
Atrial Fibrilation	9
Heart Failure	23
Chronic Obstructive Pulmonary Disease	16
Diabetes	42
Dementia	16
Cancer	24

blood draw	71
doctor visit	734
hospital care	386
inpatient care	386
lab tests	360

**Gender**
Male	207
Female	135

**Ethnicity**
Non-Hispanic White	167
Black	29
Hispanic	79
Asian	54
Other	0
Native American	0

**Age**
From 65 to 74	165
From 75 to 84	92
85 and over	19
Less than 65	66

Hypertension	72
High Cholesterol	40
Stroke	7
Ischemic Heart Disease	47
Depression	25
Chronic Kidney Disease	57
Asthma	9
Osteoperosis	9
Atrial Fibrilation	9
Heart Failure	24
Chronic Obstructive Pulmonary Disease	19
Diabetes	45
Dementia	8
Cancer	19

biological response modifier (BRM) therapy	33
blood draw	65
chemotherapy	33
doctor visit	699
hospital care	282
inpatient care	282
lab tests	299
minimally invasive procedures	33

**Gender**
Male	185
Female	122

**Ethnicity**
Non-Hispanic White	152
Black	30
Hispanic	73
Asian	41
Other	0
Native American	0

**Age**
From 65 to 74	172
From 75 to 84	77
85 and over	16
Less than 65	42

Hypertension	74
High Cholesterol	47
Stroke	6
Ischemic Heart Disease	45
Depression	30
Chronic Kidney Disease	56
Asthma	8
Osteoperosis	11
Atrial Fibrilation	11
Heart Failure	24
Chronic Obstructive Pulmonary Disease	15
Diabetes	40
Dementia	10
Cancer	20

biological response modifier (BRM) therapy	55
blood draw	108
chemotherapy	55
doctor visit	692
hospital care	291
inpatient care	291
lab tests	336
minimally invasive procedures	55

**Gender**
Male	185
Female	111

**Ethnicity**
Non-Hispanic White	154
Black	17
Hispanic	66
Asian	47
Other	0
Native American	0

**Age**
From 65 to 74	157
From 75 to 84	77
85 and over	20
Less than 65	42

Hypertension	68
High Cholesterol	46
Stroke	4
Ischemic Heart Disease	44
Depression	29
Chronic Kidney Disease	52
Asthma	10
Osteoperosis	14
Atrial Fibrilation	12
Heart Failure	22
Chronic Obstructive Pulmonary Disease	17
Diabetes	37
Dementia	11
Cancer	25

biological response modifier (BRM) therapy	119
blood draw	71
chemotherapy	119
doctor visit	781
hospital care	248
inpatient care	248
lab tests	449
minimally invasive procedures	119

**Gender**
Male	172
Female	119

**Ethnicity**
Non-Hispanic White	140
Black	26
Hispanic	68
Asian	45
Other	12
Native American	0

**Age**
From 65 to 74	161
From 75 to 84	68
85 and over	22
Less than 65	40

Hypertension	69
High Cholesterol	44
Stroke	7
Ischemic Heart Disease	43
Depression	25
Chronic Kidney Disease	51
Asthma	9
Osteoperosis	14
Atrial Fibrilation	11
Heart Failure	23
Chronic Obstructive Pulmonary Disease	15
Diabetes	40
Dementia	13
Cancer	21

biological response modifier (BRM) therapy	318
chemotherapy	318
doctor visit	1483
hospital care	670
inpatient care	670
lab tests	1222
minimally invasive procedures	318

Average Medicare Procedure Volume From 2013 - 2021

Volume of procedures performed by Dr. Richard Samuel Finn, MD for Medicare patients.

The highest averages for the top procedures that Dr. Richard Samuel Finn, MD treated as a medical oncologist in Los Angeles, CA were lab tests, hospital care, inpatient care and chemotherapy.

biological response modifier (BRM) therapy	131
blood draw	73
chemotherapy	131
doctor visit	717
hospital care	341
inpatient care	341
lab tests	382
minimally invasive procedures	131

Average Medicare Patient Data From 2013 - 2021

Information about Medicare patients treated by Dr. Richard Samuel Finn, MD.

**Gender**
Male	158
Female	105

**Ethnicity**
Black / African American	12
Asian / Pacific Islander	44
Non-Hispanic White	133
Native American / Alaskan Native	0
Hispanic	58
Other	1

**Age**
75 to 84	63
85 and over	16
Less than 65	47
65 to 74	136

Average of Total of Conditions of Medicare patients treated by Dr. Richard Samuel Finn, MD From 2013 - 2021

The highest averages of the most common conditions of Medicare patients that Dr. Richard Samuel Finn, MD treated were hypertension, chronic kidney disease, ischemic heart disease and diabetes.

Hypertension	56
High Cholesterol	33
Stroke	4
Ischemic Heart Disease	36
Depression	20
Chronic Kidney Disease	41
Asthma	8
Osteoporosis	8
Heart Failure	19
Chronic Obstructive Pulmonary Disease	13
Diabetes	33
Atrial Fibrillation	8
Cancer	17
Dementia	8

Education & Training

Dr. Richard Samuel Finn, MD graduated from University of California, Los Angeles (UCLA), David Geffen School of Medicine in 1997. He has a state license in California.

Medical School: University of California, Los Angeles (UCLA), David Geffen School of Medicine (1997)

Licensed In: California

Affiliations & Hospitals

Dr. Richard Samuel Finn, MD is associated with these hospitals and organizations:

UCLA Health

Ronald Reagan UCLA Medical Center

Huntington Health

Huntington Hospital

UCLA Santa Monica Medical Center

THE REGENTS OF THE UNIVERSITY OF CALIFORNIA

Ratings & Reviews

Dr. Richard Samuel Finn, MD does not have any reviews yet, be the first to leave a review of Dr. Richard Samuel Finn, MD here: Leave a Review

(No ratings)

Leave a Review

General Payments

These charts describe general payments received by Dr. Richard Samuel Finn, MD. Doctors may receive payments for a number of reasons, including meal compensation, travel compensation, and consulting.

**Payments by Company**
Pfizer Inc.	$267,590 IBRANCE $229,608	NonCovered Product $16,769	PREVNAR 20 $100	Non-Covered Product $59	$21,053
Bayer HealthCare Pharmaceuticals Inc.	$256,447 Stivarga $99,568	Nexavar $78,110	Non-Covered $4,025	$74,744
E.R. Squibb & Sons, L.L.C.	$104,912 OPDIVO $61,005	NIVOLUMAB $2,820	$41,087
Merck Sharp & Dohme Corporation	$103,015 KEYTRUDA $32,742	Lenvima $4,293	NON-PRODUCT $1,558	$64,422
Merck Sharp & Dohme LLC	$65,482 KEYTRUDA $32,684	Lenvima $689	$32,108
Other	$283,249 Lenvima $86,317	TECENTRIQ $81,387	IBRANCE $20,940	Cabometyx $9,200	NON BRAND $8,461	Other $76,945

**Types of Payments**
Consulting Fee	$492,520
Travel and Lodging	$282,802
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program	$269,408
Honoraria	$15,348
Food and Beverage	$13,890
Other	$6,726

Research Payments

Dr. Richard Samuel Finn, MD has received 1406 research payments totaling $9,598,526.

Biography

Dr. Richard Finn is an adult hematology, adult oncology, and medical oncology specialist. Dr. Finn is affiliated with Ronald Reagan UCLA Medical Center and Huntington Health. He attended medical school at the University of California, Los Angeles (UCLA), David Geffen School of Medicine.